missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MASP2 Monoclonal Antibody (OTI2F10), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA812533S
This item is not returnable.
View return policy
Description
MASP2 Monoclonal antibody specifically detects MASP2 in Human samples. It is validated for Western BlotSpecifications
| MASP2 | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| O00187 | |
| Mouse | |
| Protein A/G | |
| RUO | |
| 10747 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| OTI2F10 | |
| Unconjugated | |
| MASP2 | |
| mannan binding lectin serine peptidase 2; mannan-binding; mannan-binding lectin serine peptidase 1 pseudogene 1; mannan-binding lectin serine peptidase 2; mannan-binding lectin serine peptidase 2 variant 1; mannan-binding lectin serine peptidase 2 variant 2; mannan-binding lectin serine peptidase 2 variant 3; mannan-binding lectin serine peptidase 2 variant 4; mannan-binding lectin serine protease 1 pseudogene 1; mannan-binding lectin serine protease 2; Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain; mannose binding lectin-associated serine protease-2; mannose-binding protein-associated serine protease 2; MAp19; MASP1P1; Masp2; MASP-2; MBL-associated plasma protein of 19 kD; MBL-associated serine protease 2; sb:eu714; small MBL-associated protein; sMAP; wu:fb62a09 | |
| Human recombinant protein fragment corresponding to amino acids 445-686 of human MASP2 (NP_006601) produced in E.coli. | |
| 30 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG2a |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction